US Patent Issued to Mayo Foundation for Medical Education and Research on March 31 for "Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B" (Minnesota Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,165, issued on March 31, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).

"Methods and materials for identifying and treating membranous nephropathy based on elevated Semaphorin 3B" was invented by Sanjeev Sethi (Rochester, Minn.), Fernando C. Fervenza (Rochester, Minn.), Benjamin J. Madden (Stewartville, Minn.) and M. Cristine Charlesworth (Rochester, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document relates to methods and materials involved in identifying and/or treating mammals having membranous nephropathy (e.g., membranous nephropathy with an elevated level of a Semaphorin 3B polypeptide i...